Total planned funding: $271,583,648
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $271,583,648 |
Organizational Types
NGO | $73,913,833 |
Private Contractor | $56,262,749 |
Unknown | $36,636,462 |
Own Agency | $36,477,406 |
University | $32,559,168 |
Host Country Government Agency | $20,833,319 |
Parastatal | $8,596,942 |
Multi-lateral Agency | $2,646,437 |
Other USG Agency | $2,496,373 |
Implementing Agency | $1,160,959 |
FBO | $0 |
Program Areas
Treatment | $91,259,523 |
Prevention | $58,434,533 |
Care | $49,379,111 |
Governance and Systems | $33,738,802 |
Testing | $19,541,648 |
Management and Operations | $19,230,031 |
Budget Codes
HTXS: Treatment: Adult Treatment | $80,830,533 |
HKID: Care: Orphans and Vulnerable Children | $24,374,931 |
HVOP: Sexual Prevention: Other Sexual Prevention | $21,050,252 |
HVCT: Testing: HIV Testing and Counseling | $19,541,648 |
HVMS: Management and Operations | $19,230,031 |
HVSI: Strategic Information | $17,559,266 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $14,003,260 |
HBHC: Care: Adult Care and Support | $12,780,400 |
OHSS: Health Systems Strengthening | $11,632,738 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $9,185,521 |
HVTB: Care: TB/HIV | $9,080,493 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,938,245 |
HTXD: Treatment: ARV Drugs | $6,611,157 |
HLAB: Laboratory Infrastructure | $4,546,798 |
HMBL: Biomedical Prevention: Blood Safety | $3,925,217 |
PDTX: Treatment: Pediatric Treatment | $3,817,833 |
PDCS: Care: Pediatric Care and Support | $3,143,287 |
HMIN: Biomedical Prevention: Injection Safety | $2,332,038 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$34,164,672
Countries/Regions
Not Available:
$27,377,579
Countries/Regions
USG Aggregated Agencies:
$20,344,195
Countries/Regions
University of Washington:
$19,378,366
Countries/Regions